Pacira BioSciences
PCRX
PCRX
262 hedge funds and large institutions have $2.99B invested in Pacira BioSciences in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 95 increasing their positions, 84 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 270 → 262 (-8)
14% less capital invested
Capital invested by funds: $3.49B → $2.99B (-$500M)
20% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 30
Holders
262
Holding in Top 10
4
Calls
$6.13M
Puts
$3.09M
Top Buyers
| 1 | +$30.6M | |
| 2 | +$25.7M | |
| 3 | +$18.4M | |
| 4 |
Two Sigma Investments
New York
|
+$16.9M |
| 5 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$13.7M |
Top Sellers
| 1 | -$47M | |
| 2 | -$31.2M | |
| 3 | -$26.5M | |
| 4 |
Renaissance Technologies
New York
|
-$15.4M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$13.7M |